SynthesisSaudi medical journal2026
Impact of Clinical Pharmacist Educational Intervention on Lipid Profile and its Clinical Outcomes.
Synthesis in Saudi medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of Pharmacist-Led Interventions on Patient Outcomes in Gulf Cooperation Council Countries: A Systematic Review and Meta-Analysis.Pharmacy (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess how clinical pharmacist-led educational interventions affect lipid profile parameters and related clinical outcomes in cardiovascular disease-risk individuals. Methods: This systematic review completed as according to PRISMA 2020 principles. Searches were done on PubMed, ScienceDirect, ProQuest, Google Scholar, DOAJ, Scopus, and Web of Science. Studies examining impact of the pharmacists' educational initiatives on lipid levels were included. However, case reports, conference proceedings, and studies in other languages not in English, and studies lacking full-text access were excluded from the review. Following screening and eligibility assessment, a total of 33 papers were included out of the 1731 records found. These include cohort studies, pre-post investigations, and randomised controlled trials (RCTs). The methodological quality of the incorporated studies was estimated with the help of the Mixed Methods Appraisal Tool (MMAT 2018). Results: Positive changes in lipid profiles were shown by pharmacist-led educational initiatives, including reductions in LDL cholesterol, total cholesterol, and serum triglyceride levels. There were also many reports of improvements in blood pressure, lifestyle choices, glycaemic indices, HDL cholesterol (HDL-C), and medication adherence. Numerous studies demonstrated lower risk scores for cardiovascular disease (CVD) after pharmacist involvement. Clinical results were most significantly improved by interventions that incorporated medication reconciliation, lifestyle counselling, telepharmacy follow-ups, risk factor monitoring, and customised patient education. Conclusion: Through increased medication adherence, better patient awareness, and support for lifestyle adjustment, pharmacist-led educational programs greatly reduce the risk of CVD and enhanced lipid profiles. To enhance the management of chronic diseases, clinical chemists must be integrated into multidisciplinary care teams. To optimise advantages, future research should focus on standardised intervention models, cost-effectiveness assessment, and long-term cardiovascular outcome monitoring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.